OPEN enters the second week of July with its bear camp dug in — short interest has barely moved from the multi-month high set last week, the CEO is buying into the weakness, and earnings are five weeks away.
The short position remains the defining tension on this stock. Short interest held at 22.9% of free float on July 7 — effectively flat from the 22.8% reading at June 30 that the previous note flagged. The week-on-week change was a marginal +2.7%, meaning the aggressive accumulation pace from mid-June has stalled rather than reversed. Bears built roughly 48 million new short shares between early June and late June; they have neither pressed further nor covered in any meaningful size. The ORTEX short score eased slightly to 69.9 from a peak of 71.6, but that remains deep in bearish territory — OPEN still ranks in the bottom 4th percentile of the tracked universe on short pressure. Days-to-cover from the latest FINRA fortnightly print is 3.9, and given the daily-estimate trend running well above that official figure, the practical cover time is likely longer.
The borrow market has loosened relative to the squeeze conditions described a week ago. Availability recovered to around 91% — meaning there is now roughly one share available for every share already borrowed — after dropping as low as 61% on June 30. That is a meaningful shift: shares to borrow are no longer scarce, and cost to borrow has fallen back to 0.72%, down from around 0.91% at the start of the week. The loosening matters because it removes one of the technical arguments for a near-term short squeeze. With borrow now accessible, new shorts can enter without fighting for inventory. Options traders look unusually bullish by recent standards: the put/call ratio dropped to 0.19, slightly below its 20-day average of 0.20, and well below the 52-week high of 0.73. That is not a defensive posture — call volume is dominating — which sits in direct contrast to the elevated short interest reading.
The Street picture is complicated by stale data. The most recent analyst activity on record is an initiation from Alliance Global Partners at Buy with an $8 target, reported in late April. That target looks inconsistent with both the current $4.79 price and the cluster of sell-side Underperform and Sell ratings from Citigroup and Keefe Bruyette & Woods that were filed in mid-2025 at targets as low as $0.70-$1.00 — those firms have since revised up to $1.40-$2.00, still well below where the stock trades today. The analyst consensus is therefore best treated as unresolved: one recent bull at $8, a group of bears whose targets have been overtaken by the stock's move, and a mean price target of $4.82 that sits almost exactly at the current price. Factor scores add little clarity — EPS surprise ranks in the 95th percentile, a genuine positive, but EPS momentum over 30 and 90 days ranks in the bottom decile, and the short-score rank of 4 reflects the extreme positioning already discussed. EV/EBITDA has compressed by 55 points over the past 30 days, which reflects the stock's recovery from deeper lows rather than any fundamental re-rating.
The insider picture offers one concrete signal worth noting. CEO Kasra Nejatian bought 100,000 shares at $4.88 on May 11, a purchase worth roughly $488,000 with a trade significance score of 3 — the highest in the recent log. That followed a $1 million buy from the same CEO in November 2025 at $8.04, meaning the CEO has now twice bought into weakness. The CFO has sold on a regular schedule, but those transactions are small and look compensation-driven rather than directional. Morgan Stanley's investment management arm is the largest institutional holder at 9.9% of shares, having added nearly 47 million shares in its most recent reported period. That is a large position for a stock with this much short interest against it.
With Q1 earnings producing an 8% single-day decline and an 18% five-day decline in May — and the next print due August 6 — the question heading into the coming weeks is whether the short position stabilises or begins to cover as the event approaches. Availability, cost to borrow, and the ORTEX short score are the metrics to track for any early sign of a directional shift.
See the live data behind this article on ORTEX.
Open OPEN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
